Androgen priming and chemotherapy in advanced prostate cancer: evaluation of determinants of clinical outcome.
暂无分享,去创建一个
R. Santen | A. Manni | A. Lipton | H. Harvey | M. Simmonds | M. Bartholomew | R. Caplan | A. Boucher | R. Gordon | D. White‐Hershey
[1] Elisa T. Lee,et al. Statistical Methods for Survival Data Analysis , 1994, IEEE Transactions on Reliability.
[2] J. Drago,et al. Androgen priming and response to chemotherapy in advanced prostatic cancer. , 1986, The Journal of urology.
[3] J. Drago,et al. Hormone stimulation and chemotherapy in advanced prostate cancer: interim analysis of an ongoing randomized trial. , 1986, Anticancer research.
[4] R. Santen,et al. Proliferative response of the Dunning R3327H experimental model of prostatic adenocarcinoma to conditions of androgen depletion and repletion. , 1986, Cancer research.
[5] R. Priore,et al. Prognostic factors in patients with advanced stage prostate cancer. , 1985, Cancer research.
[6] D. Medina,et al. Effects of combination estrogen:cyclophosphamide treatment on the growth of the MXT transplantable mammary tumor in the mouse. , 1983, Cancer research.
[7] Allegra Jc. Methotrexate and 5-fluorouracil following tamoxifen and premarin in advanced breast cancer. , 1983 .
[8] F. Torti,et al. The chemotherapy of prostatic adenocarcinoma. , 1980, Annals of internal medicine.
[9] W. Berry,et al. Prognostic factors in metastatic and hormonally unresponsive carcinoma of the prostate , 1979, Cancer.
[10] R. Livingston,et al. Tritiated thymidine labeling index and response in human breast cancer. , 1979, Journal of the National Cancer Institute.
[11] S. Pocock. Group sequential methods in the design and analysis of clinical trials , 1977 .
[12] G. Murphy,et al. National randomized study of chemotherapeutic agents in advanced prostatic carcinoma: a progress report. , 1977, Cancer treatment reports.
[13] D. Cox,et al. The analysis of binary data , 1971 .
[14] H. Ellis,et al. Testosterone potentiated 32P therapy in prostatic carcinoma , 1966, Cancer.
[15] W. S. Maxfield,et al. The Use of Radioactive Phosphorus and Testosterone in Metastatic Bone Lesions from Breast and Prostate , 1958, Southern medical journal.
[16] J. Drago,et al. Cellular response to androgen depletion and repletion in the rat ventral prostate: Autoradiography and morphometric analysis , 1985, The Prostate.
[17] M. Lippman,et al. A randomized attempt to increase the efficacy of cytotoxic chemotherapy in metastatic breast cancer by hormonal synchronization. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] J. Drago,et al. Clinical and biochemical effect of aminoglutethimide in the treatment of advanced prostatic carcinoma. , 1983, The Journal of urology.
[19] N. Slack,et al. Response criteria for the prostate of the USA national prostatic cancer project , 1980, The Prostate.
[20] D. S. Coffey,et al. New model for studying the effects of cancer chemotherapeutic agents on the growth of the prostate gland , 1975 .
[21] D. Cox. Regression Models and Life-Tables , 1972 .